Answers are grounded in this paper and cite their sources.
Autoimmune diseases (AID) are associated with increased risk of developing gastrointestinal cancers, but their relationship with appendiceal neoplasms (AENs) remains unexplored. We performed a multi-institutional retrospective review of 179 AEN patients, identifying 44 (24.6%) with a history of AID, most commonly suspected Hashimoto’s thyroiditis (14.0%). 5-hydroxymethylcytosine (5hmC), an epigenetic marker involved in gene regulation and immune function, offers a promising tool for studying tumor biology. Plasma samples from 68 patients were analyzed using Nano-hmC-Seal (5hmC-Seal) technology to generate genome-wide 5hmC profiles from cfDNA. 5hmC profiling identified 58 candidate differentially hydroxymethylated regions (DhMRs) and 80 candidate differentially hydroxymethylated genes (DhMGs) between AID and non-AID patients based on nominal p-value and effect-size thresholds. These included. several oncogenes, proto-oncogenes, and tumor suppressor genes such as MNT, FYN, ERG, and KAT6B. Functional pathway analysis involving differentially hydroxymethylated regions or genes revealed significant hydroxymethylation of immune-related and oncogenic pathways in patients with autoimmune disease, including intestinal immune network for IgA production, along with the IgE high-affinity receptor, FcεRI, and MAPK and ErbB signaling pathways. These findings suggest that autoimmune conditions might contribute to a distinct epigenetic landscape in appendiceal cancers, supporting further investigation into immune-mediated mechanisms of tumorigenesis.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: